Covid-19 roundup: Pfizer-BioNTech ask for kid booster EUA; Novartis, Molecular Partners may need another trial for pandemic therapy

As both the debate and pressure remain around giving the youngest children a first dose of the Covid-19 vaccine, Pfizer and BioNTech are moving ahead with submitting an EUA for a Covid-19 vaccine booster dose in children ages five through 11. There are also plans to submit their data...

Click to view original post